DRTS logo

DRTS
ALPHA TAU MEDICAL LTD

1,703
Mkt Cap
$609.03M
Volume
168,396.00
52W High
$8.60
52W Low
$2.30
PE Ratio
-13.11
DRTS Fundamentals
Price
$6.92
Prev Close
$6.92
Open
$6.74
50D MA
$7.21
Beta
0.75
Avg. Volume
246,701.31
EPS (Annual)
-$0.529
P/B
7.90
Rev/Employee
$0.00
$335.70
Loading...
Loading...
News
all
press releases
DRTS Stock Is Back On Retail Radar Ahead Of High-Stakes Cancer Trial Updates
The market is awaiting the company’s patient enrolment data from pancreatic cancer and cutaneous squamous cell carcinoma trials, a key factor in advancing the studies.
Stocktwits·6d ago
News Placeholder
More News
News Placeholder
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Given Average Recommendation of "Hold" by Brokerages
Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) has received a consensus rating of "Hold" from the five brokerages that are covering the firm, Marketbeat Ratings reports. One equities research...
MarketBeat·7d ago
News Placeholder
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Here's Why
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Here's What Happened...
MarketBeat·17d ago
News Placeholder
Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased
Alpha Tau Medical (NASDAQ:DRTS) provided investors with a series of clinical, regulatory and financial updates, highlighting what company leadership described as real and meaningful activity over the...
MarketBeat·17d ago
News Placeholder
HC Wainwright Issues Pessimistic Estimate for DRTS Earnings
Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Investment analysts at HC Wainwright cut their Q1 2026 EPS estimates for shares of Alpha Tau Medical in a research report issued on Tuesday, March...
MarketBeat·24d ago
News Placeholder
Citigroup Increases Alpha Tau Medical (NASDAQ:DRTS) Price Target to $9.00
Citigroup boosted their price target on shares of Alpha Tau Medical from $7.00 to $9.00 and gave the company a "buy" rating in a research note on Wednesday...
MarketBeat·25d ago
News Placeholder
HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS)
HC Wainwright restated a "buy" rating and set a $12.00 price objective on shares of Alpha Tau Medical in a research report on Tuesday...
MarketBeat·26d ago
News Placeholder
Alpha Tau Medical (NASDAQ:DRTS) Issues Earnings Results, Misses Estimates By $0.01 EPS
Alpha Tau Medical (NASDAQ:DRTS - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.14) earnings per share for the quarter, missing analysts' consensus...
MarketBeat·26d ago
News Placeholder
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages
Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) has been given an average recommendation of "Hold" by the five analysts that are currently covering the company, Marketbeat Ratings reports. One...
MarketBeat·1mo ago
News Placeholder
Piper Sandler Reiterates Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS)
Piper Sandler reissued a "neutral" rating and issued a $5.00 price objective on shares of Alpha Tau Medical in a research report on Wednesday...
MarketBeat·1mo ago
<
1
2
...
>

Latest DRTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.